NEW YORK (GenomeWeb) – The US Food and Drug Administration said today that it is altering the way it provides 510(k) clearance for medical devices, including in vitro diagnostic products, and that the new clearance pathway will rely less on older predicate products already on the market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.